You can buy or sell GWPH and other stocks, options, ETFs, and crypto commission-free!
GW Pharmaceuticals Plc American Depositary Shares, also called GW Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. Read More The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.
52 Week High
52 Week Low
Expected Nov 12, After Hours
GW Pharma CEO: More education needed on real health benefits of drugs derived from cannabis
GW Pharma Rallies On Strong Q2 Epidiolex Sales, Says European Approval Expected In October